Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6SF8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,961
Award facts
- Contract value 100% obligated
- $30,960.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,960.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen (semaglutide), a GLP-1 receptor agonist used in diabetes and weight management treatment. This competitively awarded, non-set-aside contract was executed on January 14, 2026, with an ultimate completion date of January 15, 2026, and performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order was issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements for diverse pharmaceutical products ranging from specialty medications to essential medical supplies supporting military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F6SF8?
SPE2DR26F6SF8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F6SF8 worth?
The government has obligated $30,961 on SPE2DR26F6SF8.
Is contract SPE2DR26F6SF8 an order under another contract?
Yes. SPE2DR26F6SF8 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SF8 competed?
The extent of competition for SPE2DR26F6SF8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award